The knowns and unknowns of SSRI treatment in young people with depression and anxiety: efficacy, predictors, and mechanisms of action

The knowns and unknowns of SSRI treatment in young people with depression and anxiety: efficacy, predictors, and mechanisms of action

The use of SSRIs for the treatment of depression and anxiety in young people is increasing. However, the effects of SSRIs in adolescence, a time when there are substantial changes in neural, cognitive, and social functioning, are not well understood. Here, we review evidence from clinical trials abo...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Murphy, SE, Capitão, LP, Giles, SLC, Cowen, PJ, Stringaris, A, Harmer, CJ
Format:	Journal article
Język:	English
Wydane:	Elsevier 2021

Podobne zapisy

'It's the way that you look at it'--a cognitive neuropsychological account of SSRI action in depression.
od: Harmer, C, i wsp.
Wydane: (2013)

'It's the way that you look at it'--a cognitive neuropsychological account of SSRI action in depression.
od: Harmer, C, i wsp.
Wydane: (2013)

SSRI enhances sensitivity to background outcomes and modulates response rates: A randomized double blind study of instrumental action and depression
od: Msetfi, RM, i wsp.
Wydane: (2016)

Neural response to implicit emotions as biomarkers of clinical response to SSRI treatment in depression
od: Godlewska, B, i wsp.
Wydane: (2017)

Acute neural effects of fluoxetine on emotional regulation in depressed adolescents
od: Capitão, LP, i wsp.
Wydane: (2022)

Does tryptophan supplementation induce similar changes in emotional processing to an SSRI?
od: Murphy, SE, i wsp.
Wydane: (2005)

Depression and anxiety disorders during the COVID-19 pandemic: knowns and unknowns
od: Taquet, M, i wsp.
Wydane: (2021)

Short-term SSRI treatment remediates amygdala hyperactivity in depressed patients
od: Godlewska, B, i wsp.
Wydane: (2011)

Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients.
od: Godlewska, B, i wsp.
Wydane: (2012)

Effect of the NMDA receptor partial agonist, d-cycloserine, on emotional processing and autobiographical memory
od: Chen, R, i wsp.
Wydane: (2020)

Using pharmacological fMRI to examine the effect of an SSRI on the neural circuitry underpinning threat processing
od: Murphy, SE, i wsp.
Wydane: (2008)

Fronto-limbic effective connectivity as possible predictor of antidepressant response to SSRI administration
od: Vai, B, i wsp.
Wydane: (2016)

Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression.
od: Bhagwagar, Z, i wsp.
Wydane: (2004)

Early changes in emotional processing as a marker of clinical response to SSRI treatment in depression
od: Godlewska, B, i wsp.
Wydane: (2016)

SHORT-TERM SSRI TREATMENT REMEDIATES AMYGDALA HYPERACTIVITY IN DEPRESSED PATIENTS: A PLACEBO-CONTROLLED STUDY
od: Godlewska, B, i wsp.
Wydane: (2011)

Augmentation of SSRI treatment
od: Cowen, P
Wydane: (2008)

The serotonin 1A (5-HT1A) receptor as a pharmacological target in depression
od: Smith, ALW, i wsp.
Wydane: (2023)

Using pharmacological fMRI to examine the effect of an SSRI on the neural circuitry underpinning threat processing
od: Murphy, S, i wsp.
Wydane: (2008)

Mechanisms of enhancer action: the known and the unknown
od: Anil Panigrahi, i wsp.
Wydane: (2021-04-01)

Acute SSRI administration affects the processing of social cues in healthy volunteers.
od: Harmer, C, i wsp.
Wydane: (2003)

Olanzapine increases slow wave sleep and sleep continuity in SSRI-resistant depressed patients.
od: Sharpley, A, i wsp.
Wydane: (2005)

The effect of the 5-HT4 agonist, Prucalopride, on a functional magnetic resonance imaging faces task in the healthy human brain
od: de Cates, AN, i wsp.
Wydane: (2022)

Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research
od: Colwell, MJ, i wsp.
Wydane: (2022)

SSRI administration reduces resting state functional connectivity in dorso-medial prefrontal cortex
od: McCabe, C, i wsp.
Wydane: (2011)

SSRI administration reduces resting state functional connectivity in dorso-medial prefrontal cortex.
od: McCabe, C, i wsp.
Wydane: (2011)

Differences between SSRI and SNRI in depression treatment
od: Mateusz Grego, i wsp.
Wydane: (2025-01-01)

Association between a selective 5-HT4 receptor agonist and incidence of major depressive disorder: emulated target trial
od: de Cates, AN, i wsp.
Wydane: (2024)

The Known Into the Unknown
od: Antonio Sorgente, MD, PhD, i wsp.
Wydane: (2020-07-01)

The known and the unknown
od: Editorial
Wydane: (2010-01-01)

The known knowns and known unknowns of peacekeeping data
od: Dorussen, H, i wsp.
Wydane: (2016)

Anxiety increases breakthrough of threat stimuli in continuous flash suppression.
od: Capitão, L, i wsp.
Wydane: (2014)

Statins in depression: a repurposed medical treatment can provide novel insights in mental health
od: De Giorgi, R, i wsp.
Wydane: (2022)

Thyroid hormone action in adult neurogliogenic niches: the known and unknown
od: Victor Valcárcel-Hernández, i wsp.
Wydane: (2024-03-01)

Restless Legs Syndrome: Known Knowns and Known Unknowns
od: Elena Antelmi, i wsp.
Wydane: (2022-01-01)

Translating the promise of 5HT4 receptor agonists for the treatment of depression
od: Murphy, SE, i wsp.
Wydane: (2020)

SSRI treatment decreases prolactin and hyperthermic responses to mCPP.
od: Quested, D, i wsp.
Wydane: (1997)

A translational perspective on the anti-anhedonic effect of ketamine and its neural underpinnings
od: Pulcu, E, i wsp.
Wydane: (2021)

Cardioneuroablation: the known and the unknown
od: A. Marrese, i wsp.
Wydane: (2024-07-01)

Vildagliptin: the known and unknown
od: L. Y. Morgunov
Wydane: (2016-12-01)

Anxiety increases breakthrough of threat stimuli in continuous flash suppression
od: Yang, E, i wsp.
Wydane: (2014)